BioDelivery Sciences (BDSI) Misses Q4 EPS by 3c

March 17, 2017 6:37 AM EDT

BioDelivery Sciences (NASDAQ: BDSI) reported Q4 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $3.88 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings